<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="lead">
            <roleset id="lead.01" name="resulted&#x0A;" wordnet="3">
                <roles>
                    <role n="0" descr="factors&#x0A;" />
                    <role n="2" descr="result&#x0A;" />
                </roles>
                <example src="EGRAM" no="0">
                    <text>The loss of the TreR function will lead to the derepression of the treB encoding an enzyme of the PTS for the trehalose and treC, the cytoplasmic trehalose-6-phosphate hydrolasa.</text>
                    <arg n="0">loss of the TreR function</arg>
                    <arg n="1">derepression of the treB</arg>
                </example>
                <example src="EGRAM" no="1">
                    <text>This data suggests that phosphorylation of the site NPXY MuSK led to recovery of a domain protein bound to phosphorosine that works to stimulate phosphorylation and AchRs grouping.</text>
                    <arg n="0">phosphorylation of the site NPXY MuSK</arg>
                    <arg n="1">recovery of a domain protein bound to phosphorosine</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>A0 (i.e., in turn, led to synergic activation of the ANA and other target promoters of MEF2 regardless of the binding activity of meF2.</text>
                    <arg n="1">synergic activation of the ANA and other target promoters of MEF2</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>Crl stimulates sigma activity (S) will lead to an increase in the transcription rate of a subset of regulatory rpoS genes in the stationary phase.</text>
                    <arg n="0">Crl stimulates sigma activity (S)</arg>
                    <arg n="1">an increase in the transcription rate of a subset of regulatory rpoS genes in the stationary phase</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>GATA-4 cotransformation with MEF2A, MEF2C or MEF2D, in turn, is leading to a 40 to 50-fold synergistic activation of the aF promoter regardless of the DNA binding activity of MEF2.</text>
                    <arg n="0">GATA-4 cotransformation with MEF2A, MEF2C or MEF2D</arg>
                    <arg n="1">a 40 to 50-fold synergistic activation of the aF promoter</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>In addition, experiments with an antisense DNA expression vector cDNA introduced in cultivated cells suggest that the interaction phosphorylation of the MuSK site NPXY leads to recovery of a protein bound to phosphorosine.</text>
                    <arg n="0">phosphorylation of the MuSK site NPXY</arg>
                    <arg n="1">recovery of a protein bound to phosphorosine</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>In addition, experiments with an antisense DNA expression vector cDNA introduced in cultivated cells suggest that the interaction this leads to a substantial diversity of isoforms of nebulin and nebulette.</text>
                    <arg n="0">this</arg>
                    <arg n="1">a substantial diversity of isoforms of nebulin and nebulette</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>In this homologous part of genes, GBP lacks an exon due to growth of scherichia coli in the presence of nitrate or nitrite, which inactivates the fifth segmentation event of the application of the cleavage and is able to lead to a 45% drop in expression.</text>
                    <arg n="0">growth of scherichia coli in the presence of nitrate or nitrite</arg>
                    <arg n="1">a 45% drop in expression</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>In this homologous part of genes, GPB does not have an exon due to the closest test to the putative signal transduction pathway that modulates the htrA transcription, which inactivates the pulse event of the 5th and may lead to identification of two new genes.</text>
                    <arg n="0">the closest test to the putative signal transduction pathway that modulates the htrA transcription</arg>
                    <arg n="1">identification of two new genes</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>In this homologous part of the genes, GBP does not have an exon due to GATA-4 co-transfection with MEF2A, MEF2C or MEF2D, which inactivates the pulse segmentation event and leads to a synergistic activation of 40 to 50 folds of the promoter ANA.</text>
                    <arg n="0">GATA-4 co-transfection with MEF2A, MEF2C or MEF2D</arg>
                    <arg n="1">a synergistic activation of 40 to 50 folds of the promoter ANA</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>In this homologous part of the genes, GBP does not have an exon due to This, which inactivates the pulse segmentation event and leads to synergistic activation of ANA and other target promoters of MEF2.</text>
                    <arg n="0">This</arg>
                    <arg n="1">synergistic activation of ANA and other target promoters of MEF2</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>The Crl stimulates sigma activity (S) led to an increase in the transcription rate of a subset of regulatory rpoS genes in the stationary phase.</text>
                    <arg n="0">Crl stimulates sigma activity (S)</arg>
                    <arg n="1">an increase in the transcription rate of a subset of regulatory rpoS genes in the stationary phase</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>The a closer examination of the transduction pathway of putative signals that modulates the HtrA transcription can lead to the the identification of two new genes appears to be one of the causes of the X-linked recessive adreoleukodropy.</text>
                    <arg n="0">a closer examination of the transduction pathway of putative signals that modulates the HtrA transcription</arg>
                    <arg n="1">the identification of two new genes</arg>
                </example>
                <example src="PERMUTATE" no="12">
                    <text>The growth of scherichia coli in the presence of nitrate or nitrite led to a 45% drop in expression.</text>
                    <arg n="0">growth of scherichia coli in the presence of nitrate or nitrite</arg>
                    <arg n="1">a 45% drop in expression</arg>
                </example>
                <example src="PERMUTATE" no="13">
                    <text>The mutations identified include: Crl stimulates sigma activity (S) that led to an increase in the transcription rate of a subset of rpoS genes in the stationary phase, two of them involving amino acids within the transmembrane putative domains.</text>
                    <arg n="0">Crl stimulates sigma activity (S)</arg>
                    <arg n="1">an increase in the transcription rate of a subset of rpoS genes in the stationary phase</arg>
                </example>
                <example src="PERMUTATE" no="14">
                    <text>The phosphorylation of the MuSK site NPXY leads to the capture of a phosphorosine binding protein appears to be one of the causes of X-linked recessive adreoleukodrophite.</text>
                    <arg n="0">phosphorylation of the MuSK site NPXY</arg>
                    <arg n="1">capture of a phosphorosine binding protein</arg>
                </example>
                <example src="PERMUTATE" no="15">
                    <text>These data suggest that closer to the transduction pathway of the putative signal that modulates htrA transcription may lead to the identification of two new genes that works to stimulate phosphorylation and clustering of AchRs.</text>
                    <arg n="0">closer to the transduction pathway of the putative signal that modulates htrA transcription</arg>
                    <arg n="1">the identification of two new genes</arg>
                </example>
                <example src="PERMUTATE" no="16">
                    <text>These data suggest that growth of scherichia coli in the presence of nitrate or nitrite led to a 45% drop in expression that works to stimulate phosphorylation and clustering of AchRs.</text>
                    <arg n="0">growth of scherichia coli in the presence of nitrate or nitrite</arg>
                    <arg n="1">a 45% drop in expression</arg>
                </example>
                <example src="PERMUTATE" no="17">
                    <text>This DNA of patients contains closer to the transduction pathway of the putative signal that modulates htrA transcription that led to the identification of two new genes.</text>
                    <arg n="0">closer to the transduction pathway of the putative signal that modulates htrA transcription</arg>
                    <arg n="1">the identification of two new genes</arg>
                </example>
                <example src="PERMUTATE" no="18">
                    <text>This DNA of patients contains cut switch at 5 ends of the intron 5 allele that can lead to normal exon 5 and portion of exon 6.</text>
                    <arg n="0">cut switch at 5 ends of the intron 5</arg>
                    <arg n="1">normal exon 5 and portion of exon 6</arg>
                </example>
                <example src="PERMUTATE" no="19">
                    <text>This base pair G:C is also the strongest determinant in a mutation point (GTC---ATC) in codon 383 that has led to the conservative substitution of isoleucine by valine in the putative fifth extracellular transporter loop (Lagrange et al., 1998).</text>
                    <arg n="0">a mutation point (GTC---ATC) in codon 383</arg>
                    <arg n="1">the conservative substitution of isoleucine by valine in the putative fifth extracellular transporter loop</arg>
                </example>
                <example src="PERMUTATE" no="20">
                    <text>This base pair G:C is also the strongest determinant in growth of scherichia coli in the presence of nitrate or nitrite leads to a 45% drop in expression (Lagrange et al., 1998).</text>
                    <arg n="0">growth of scherichia coli in the presence of nitrate or nitrite</arg>
                    <arg n="1">a 45% drop in expression</arg>
                </example>
                <example src="PERMUTATE" no="21">
                    <text>This basic pair G:C is also the strongest determinant in nCaRE that leads to C2+e-mediated transcriptional supression (Lagrange et al., 1998).</text>
                    <arg n="0">nCaRE</arg>
                    <arg n="1">C2+e-mediated transcriptional supression</arg>
                </example>
                <example src="PERMUTATE" no="22">
                    <text>This data suggests that a closer examination of the transduction pathway of putative signals that modulates the transcription htrA has led to the identification of two new genes that works to stimulate phosphorylation and AchRs grouping.</text>
                    <arg n="0">a closer examination of the transduction pathway of putative signals that modulates the transcription htrA</arg>
                    <arg n="1">the identification of two new genes</arg>
                </example>
                <example src="PERMUTATE" no="23">
                    <text>This data suggests that a mutation point (GTC---ATC) in codon 383 can lead to the conservative substitution of isoleucine by valine in the putative fifth extracellular transporter loop that works to stimulate phosphorylation and AchRs grouping.</text>
                    <arg n="0">a mutation point (GTC---ATC) in codon 383</arg>
                    <arg n="1">the conservative substitution of isoleucine by valine in the putative fifth extracellular transporter loop</arg>
                </example>
                <example src="PERMUTATE" no="24">
                    <text>This data suggests that phosphorylation of the site NPXY MuSK led to recovery of a domain protein bound to phosphotyrosine working to stimulate phosphorylation and clustering of AchRs.</text>
                    <arg n="0">phosphorylation of the site NPXY MuSK</arg>
                    <arg n="1">recovery of a domain protein bound to phosphotyrosine</arg>
                </example>
                <example src="PERMUTATE" no="25">
                    <text>This patient DNA contains Crl stimulates sigma activity (S) leads to an increase in the rate of transcription of a subset of rpoS genes in the stationary phase.</text>
                    <arg n="0">Crl stimulates sigma activity (S)</arg>
                    <arg n="1">an increase in the rate of transcription of a subset of rpoS genes in the stationary phase</arg>
                </example>
                <example src="PERMUTATE" no="26">
                    <text>This patient DNA contains This leads to synergistic activation of ANA and other target promoters of MEF2.</text>
                    <arg n="0">This</arg>
                    <arg n="1">synergistic activation of ANA and other target promoters of MEF2</arg>
                </example>
                <example src="PERMUTATE" no="27">
                    <text>This patient DNA contains this leads to a substantial diversity of isoforms of nebulin and nebulae.</text>
                    <arg n="0">this</arg>
                    <arg n="1">a substantial diversity of isoforms of nebulin and nebulae</arg>
                </example>
                <example src="PERMUTATE" no="28">
                    <text>This was caused by Loss of TreR function leading to derepression of treB.</text>
                    <arg n="0">Loss of TreR function</arg>
                    <arg n="1">derepression of treB</arg>
                </example>
                <example src="PERMUTATE" no="29">
                    <text>This was caused by a closer analysis of the putative signal transduction pathway that modulates HtrA transcription which leading to the identification of two new genes.</text>
                    <arg n="0">a closer analysis of the putative signal transduction pathway that modulates HtrA transcription</arg>
                    <arg n="1">the identification of two new genes</arg>
                </example>
                <example src="PERMUTATE" no="30">
                    <text>This was caused by a closer analysis of the putative signal transduction pathway that modulates HtrA transcription which led to the identification of two new genes.</text>
                    <arg n="0">a closer analysis of the putative signal transduction pathway that modulates HtrA transcription</arg>
                    <arg n="1">the identification of two new genes</arg>
                </example>
                <example src="PERMUTATE" no="31">
                    <text>This was caused by growth of scherichia coli in the presence of nitrate or nitrite that leads to a 45% drop in expression.</text>
                    <arg n="0">growth of scherichia coli in the presence of nitrate or nitrite</arg>
                    <arg n="1">a 45% drop in expression</arg>
                </example>
                <example src="PERMUTATE" no="32">
                    <text>This was caused by mutation of cut at 5 ends of the intron 5 leads to abnormal exon 5 and portion of exon 6.</text>
                    <arg n="0">mutation of cut at 5 ends of the intron 5</arg>
                    <arg n="1">abnormal exon 5 and portion of exon 6</arg>
                </example>
                <example src="PERMUTATE" no="33">
                    <text>This was caused by phosphorylation of the MuSK site NPXY that leads to recovery of a protein bound to phosphorosine.</text>
                    <arg n="0">phosphorylation of the MuSK site NPXY</arg>
                    <arg n="1">recovery of a protein bound to phosphorosine</arg>
                </example>
                <example src="PERMUTATE" no="34">
                    <text>This was caused by with two exchanges of frames and a mutation at the fitting site that led to elongated OA1 proteins; removal of a threonine codon at position 290; and four mutations of the reverse direction.</text>
                    <arg n="0">with two exchanges of frames and a mutation at the fitting site</arg>
                    <arg n="1">elongated OA1 proteins; removal of a threonine codon at position 290; and four mutations of the reverse direction</arg>
                </example>
                <example src="PERMUTATE" no="35">
                    <text>Transduction of the mara region from a sea strain, but not a wild-type strain, leads to the loss of OmpF.</text>
                    <arg n="0">the loss of OmpF</arg>
                </example>
                <example src="PERMUTATE" no="36">
                    <text>a C----A transversion following the last intron sneezing aceptor of the only ERCC-3 allele led to an insertion of 4 bp into RNAm and an inactivating frameshift into the C-thermoid of the protein (figure 3A).</text>
                    <arg n="0">a C----A transversion following the last intron sneezing aceptor of the only ERCC-3 allele</arg>
                    <arg n="1">an insertion of 4 bp into RNAm and an inactivating frameshift into the C-thermoid of the protein</arg>
                </example>
                <example src="PERMUTATE" no="37">
                    <text>a C----A transversion following the last intron sneezing aceptor of the only ERCC-3 allele led to an insertion of 4 bp into RNAm and an inactivating frameshift into the C-thermoid of the protein, an atypical form of Tay-Sachs disease (gM2 variant of AB limphosidosis).</text>
                    <arg n="0">a C----A transversion following the last intron sneezing aceptor of the only ERCC-3 allele</arg>
                    <arg n="1">an insertion of 4 bp into RNAm and an inactivating frameshift into the C-thermoid of the protein</arg>
                </example>
                <example src="PERMUTATE" no="38">
                    <text>a C---A transversion in the helix sequence of the last intron of the only ERCC-3 allele can lead to an insertion of 4 bp into the mRNA and an inactive frame shift in the proteins terminal C.</text>
                    <arg n="0">a C---A transversion in the helix sequence of the last intron of the only ERCC-3 allele</arg>
                    <arg n="1">an insertion of 4 bp into the mRNA and an inactive frame shift in the proteins terminal C</arg>
                </example>
                <example src="PERMUTATE" no="39">
                    <text>a C---A transversion in the helix sequence of the last intron of the only ERCC-3 allele led to an insertion of 4 bp into the mRNA and an inactive frame shift in the proteins terminal C, an atypical form of Tay-Sachs disease (gM2 variant of AB limphosidosis).</text>
                    <arg n="0">a C---A transversion in the helix sequence of the last intron of the only ERCC-3 allele</arg>
                    <arg n="1">an insertion of 4 bp into the mRNA and an inactive frame shift in the proteins terminal C</arg>
                </example>
                <example src="PERMUTATE" no="40">
                    <text>a closer examination of the transfer pathway of putative signals that modulates the transcription htrA can lead to the identification of two new genes, an atypical form of Tay-Sachs disease (gM2 variant of limphosis AB).</text>
                    <arg n="0">a closer examination of the transfer pathway of putative signals that modulates the transcription htrA</arg>
                    <arg n="1">the identification of two new genes</arg>
                </example>
                <example src="PERMUTATE" no="41">
                    <text>a neurological disease is led to genetic deficiency of the GM2 activator.</text>
                    <arg n="0">genetic deficiency of the GM2 activator</arg>
                    <arg n="1">a neurological disease</arg>
                </example>
                <example src="PERMUTATE" no="42">
                    <text>a neurological disorder was led to genetic deficiency of the GM2 activator.</text>
                    <arg n="0">genetic deficiency of the GM2 activator</arg>
                    <arg n="1">a neurological disorder</arg>
                </example>
                <example src="PERMUTATE" no="43">
                    <text>a point mutation (GTC---ATC) in codon 383 is leading to conservative substitution of isoleucine for valine in the transporters fifth extracellular putative loop.</text>
                    <arg n="0">a point mutation (GTC---ATC) in codon 383</arg>
                    <arg n="1">conservative substitution of isoleucine for valine in the transporters fifth extracellular putative loop</arg>
                </example>
                <example src="PERMUTATE" no="44">
                    <text>a punctual mutation (GTC----ATC) in codon 383 led to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter, an atypical form of Tay-Sachs disease (gM2 variant of AB limphosidosis).</text>
                    <arg n="0">a punctual mutation (GTC----ATC) in codon 383</arg>
                    <arg n="1">the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter</arg>
                </example>
                <example src="PERMUTATE" no="45">
                    <text>a punctual mutation (GTC----ATC) in codon 383 will lead to conserved replacement of isoleucine by valine in the putative fifth extracellular loop of the transporter coding an enzyme IITre of PTS for trehalose and the TreC coding enzyme TreC, cytoplasmic trehalose-6-phosphate-hydroxylase.</text>
                    <arg n="0">a punctual mutation (GTC----ATC) in codon 383</arg>
                    <arg n="1">conserved replacement of isoleucine by valine in the putative fifth extracellular loop of the transporter</arg>
                </example>
                <example src="PERMUTATE" no="46">
                    <text>mutation of cut at 5 ends of the intron 5 is leading to abnormal exon 5 and portion of exon 6.</text>
                    <arg n="0">mutation of cut at 5 ends of the intron 5</arg>
                    <arg n="1">abnormal exon 5 and portion of exon 6</arg>
                </example>
                <example src="PERMUTATE" no="47">
                    <text>mutation of cut at 5 ends of the intron 5 will lead to abnormal exon 5 and portion of exon 6.</text>
                    <arg n="0">mutation of cut at 5 ends of the intron 5</arg>
                    <arg n="1">abnormal exon 5 and portion of exon 6</arg>
                </example>
                <example src="PERMUTATE" no="48">
                    <text>mutation of cutting at 5 ends of the intron 5 led normal exon 5 and portion of exon 6 to codify a PTS enzyme IITre for trealose and to codify treC TreC, trealose-6-phosphate-hydroxylase cytoplasmic.</text>
                    <arg n="0">mutation of cutting at 5 ends of the intron 5</arg>
                    <arg n="1">normal exon 5 and portion of exon 6</arg>
                </example>
                <example src="PERMUTATE" no="49">
                    <text>nCaRE led C2+e-mediated transcriptional supression to codify a PTS enzyme IITre for trealose and to codify treC TreC, trealose-6-phosphate-hydroxylase cytoplasmic.</text>
                    <arg n="0">nCaRE</arg>
                    <arg n="1">C2+e-mediated transcriptional supression</arg>
                </example>
                <example src="PERMUTATE" no="50">
                    <text>nCaRE may lead to C2+e-mediated transcriptional supression (figure 3A).</text>
                    <arg n="0">nCaRE</arg>
                    <arg n="1">C2+e-mediated transcriptional supression</arg>
                </example>
                <example src="PERMUTATE" no="51">
                    <text>recovery of a domain protein bound to phosphorosine was led to phosphorylation of the site NPXY MuSK.</text>
                    <arg n="0">phosphorylation of the site NPXY MuSK</arg>
                    <arg n="1">recovery of a domain protein bound to phosphorosine</arg>
                </example>
                <example src="PERMUTATE" no="52">
                    <text>this has led in a substantial diversity of isoforms of nebulin and nebulette.</text>
                    <arg n="0">this</arg>
                    <arg n="1">a substantial diversity of isoforms of nebulin and nebulette</arg>
                </example>
                <example src="PERMUTATE" no="53">
                    <text>two changes in the picture and one mutation at the fitting site has led in oA1 proteins, removal of a threonine codon at position 290, and four mutations of the reverse direction.</text>
                    <arg n="0">two changes in the picture and one mutation at the fitting site</arg>
                    <arg n="1">oA1 proteins, removal of a threonine codon at position 290, and four mutations of the reverse direction</arg>
                </example>
                <example src="REPLACE" no="1">
                    <text>7 absent mutations, 2 mutations base pair G:C is also the strongest determinant in This that led to shifting in frames (Lagrange et al., 1998).</text>
                    <arg n="0">7 absent mutations, 2 mutations</arg>
                    <arg n="1">shifting in frames</arg>
                </example>
                <example src="REPLACE" no="2">
                    <text>7 senseless mutations, 2 mutations patient DNA contains This that can lead to frame shift.</text>
                    <arg n="0">7 senseless mutations, 2 mutations</arg>
                    <arg n="1">frame shift</arg>
                </example>
                <example src="REPLACE" no="3">
                    <text>Display of the SNU246 gene in yeast was caused by This leads to a defect of in vivo splicing, indicating that the protein is essential for splicing.</text>
                    <arg n="0">Display of the SNU246 gene in yeast</arg>
                    <arg n="1">a defect of in vivo splicing, indicating that the protein is essential for splicing</arg>
                </example>
                <example src="REPLACE" no="4">
                    <text>G979A affected a consensus site of the splice at the end of exon 8, and G1488T at exon 14 was caused by This which has led to a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S).</text>
                    <arg n="0">G979A affected a consensus site of the splice at the end of exon 8, and G1488T at exon 14</arg>
                    <arg n="1">a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S)</arg>
                </example>
                <example src="REPLACE" no="5">
                    <text>G979A affects a consensual site of the splice at the end of exon 8, and G1488T at exon 14 basic pair G:C is also the strongest determinant in This that led to a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S) (Lagrange et al., 1998).</text>
                    <arg n="0">G979A affects a consensual site of the splice at the end of exon 8, and G1488T at exon 14</arg>
                    <arg n="1">a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S)</arg>
                </example>
                <example src="REPLACE" no="6">
                    <text>G979A affects a splice consensus site at the end of exon 8, and G1488T at exon 14 DNA of patients contains This that led to a substitution of a positive load in a highly conserved transmembrane domain (R496S).</text>
                    <arg n="0">G979A affects a splice consensus site at the end of exon 8, and G1488T at exon 14</arg>
                    <arg n="1">a substitution of a positive load in a highly conserved transmembrane domain (R496S)</arg>
                </example>
                <example src="REPLACE" no="7">
                    <text>In addition, experiments with an antisense DNA expression vector cDNA introduced in cultivated cells suggest that the interaction this mutation at 5 ends of the intron 5 leads to abnormal portion in exon 5 and exon 6.</text>
                    <arg n="0">this mutation at 5 ends of the intron 5</arg>
                    <arg n="1">abnormal portion in exon 5 and exon 6</arg>
                </example>
                <example src="REPLACE" no="8">
                    <text>In addition, experiments with an antisense DNA expression vector cDNA introduced in cultivated cells suggested that the interaction 7 absent mutations, 2 mutations-ref1 could lead to transcriptional suppression C2+e.</text>
                    <arg n="0">7 absent mutations, 2 mutations</arg>
                </example>
                <example src="REPLACE" no="9">
                    <text>In addition, experiments with an antisense DNA expression vector cDNA introduced in cultivated cells suggested that the interaction growth of Escherichia coli in the presence of nitrate or nitrite-ref1 could lead to transcriptional suppression C2+e.</text>
                    <arg n="0">growth of Escherichia coli in the presence of nitrate or nitrite</arg>
                </example>
                <example src="REPLACE" no="10">
                    <text>In addition, experiments with an antisense DNA expression vector cDNA introduced in cultivated cells suggested that the interaction the different amino terminals-ref1 had led to transcriptional suppression C2+e.</text>
                    <arg n="0">the different amino terminals</arg>
                </example>
                <example src="REPLACE" no="11">
                    <text>In addition, experiments with an antisense cDNA DNA expression vector introduced in cultivated cells suggest that the interaction G979A affects a consensual site of the splice at the end of exon 8, and G1488T at exon 14 leads to a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S).</text>
                    <arg n="0">G979A affects a consensual site of the splice at the end of exon 8, and G1488T at exon 14</arg>
                    <arg n="1">a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S)</arg>
                </example>
                <example src="REPLACE" no="12">
                    <text>In addition, experiments with antisense-ref cDNA expression vector introduced in cultivated cells suggest that the interaction inactivation of the MEF2C gene-ref1 is able to lead to transcriptional suppression morphogenetic cardiac defects, vascular abnormalities and mortality by day 9.5 embryo.</text>
                    <arg n="0">inactivation of the MEF2C gene</arg>
                    <arg n="1">morphogenetic cardiac defects, vascular abnormalities and mortality by day 9.5 embryo</arg>
                </example>
                <example src="REPLACE" no="13">
                    <text>In addition, experiments with antisense-ref cDNA expression vector introduced in cultivated cells suggest that the interaction inactivation of the MEF2C gene-ref1 is able to lead to transcriptional suppression morphogenetic cardiac defects, vascular abnormalities, and death on the 9.5 embryos.</text>
                    <arg n="0">inactivation of the MEF2C gene</arg>
                    <arg n="1">morphogenetic cardiac defects, vascular abnormalities, and death on the 9.5 embryos</arg>
                </example>
                <example src="REPLACE" no="14">
                    <text>The the different amino acid terminals can lead to the the orientation of individual VDAC isoforms to different cellular compartments appears to be one of the causes of the X-linked recessive adreoleukodropy.</text>
                    <arg n="0">the different amino acid terminals</arg>
                    <arg n="1">the orientation of individual VDAC isoforms to different cellular compartments</arg>
                </example>
                <example src="REPLACE" no="15">
                    <text>The the different amino acid terminals led to the the orientation of individual VDAC isoforms to different cellular compartments appears to be one of the causes of the X-linked recessive adreolechodrophy.</text>
                    <arg n="0">the different amino acid terminals</arg>
                    <arg n="1">the orientation of individual VDAC isoforms to different cellular compartments</arg>
                </example>
                <example src="REPLACE" no="16">
                    <text>The two frame shifts and a mutation of the splice site led to the shortened OA1 proteins; removal of a threonine codon at position 290; and four opposite-sense mutations appears to be one of the causes of the X-linked recessive adreolechodrophy.</text>
                    <arg n="0">two frame shifts and a mutation of the splice site</arg>
                    <arg n="1">shortened OA1 proteins; removal of a threonine codon at position 290; and four opposite-sense mutations</arg>
                </example>
                <example src="REPLACE" no="17">
                    <text>This DNA of patients contains a complex mutation of the coupling site allele that can lead to an altered JNA, resulting in a premature arrest codon.</text>
                    <arg n="0">a complex mutation of the coupling site</arg>
                    <arg n="1">an altered JNA, resulting in a premature arrest codon</arg>
                </example>
                <example src="REPLACE" no="18">
                    <text>This DNA of patients contains the mutation of the splice at 5 ends of the intron 5 allele that can lead to the abnormal splice in exon 5 and exon 6.</text>
                    <arg n="0">the mutation of the splice at 5 ends of the intron 5</arg>
                    <arg n="1">the abnormal splice in exon 5 and exon 6</arg>
                </example>
                <example src="REPLACE" no="19">
                    <text>This base pair G:C is also the strongest determinant in a complex mutation of the coupling site leading to an altered JNA, resulting in a premature arrest codon (Lagrange et al., 1998).</text>
                    <arg n="0">a complex mutation of the coupling site</arg>
                    <arg n="1">an altered JNA, resulting in a premature arrest codon</arg>
                </example>
                <example src="REPLACE" no="20">
                    <text>This data suggests that G979A affects a consensual site of splices at the end of exon 8, and G1488T at exon 14 has led to a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S) that works to stimulate phosphorylation and AchRs grouping.</text>
                    <arg n="0">G979A affects a consensual site of splices at the end of exon 8, and G1488T at exon 14</arg>
                    <arg n="1">a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S)</arg>
                </example>
                <example src="REPLACE" no="21">
                    <text>This data suggests that inactivation of the MEF2C gene led to morphogenetic cardiac defects, vascular abnormalities and mortality at day 9.5 embryonic that works to stimulate phosphorylation and AchRs grouping.</text>
                    <arg n="0">inactivation of the MEF2C gene</arg>
                    <arg n="1">morphogenetic cardiac defects, vascular abnormalities and mortality at day 9.5 embryonic</arg>
                </example>
                <example src="REPLACE" no="22">
                    <text>This patient DNA contains inactivation of the MEF2C gene that can lead to morphogenetic cardiac defects, vascular abnormalities and mortality at day 9.5 embryonic.</text>
                    <arg n="0">inactivation of the MEF2C gene</arg>
                    <arg n="1">morphogenetic cardiac defects, vascular abnormalities and mortality at day 9.5 embryonic</arg>
                </example>
                <example src="REPLACE" no="23">
                    <text>This was caused by G979A affects a consensual site of the splice at the end of exon 8, and G1488T at exon 14 leads to a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S).</text>
                    <arg n="0">G979A affects a consensual site of the splice at the end of exon 8, and G1488T at exon 14</arg>
                    <arg n="1">a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S)</arg>
                </example>
                <example src="REPLACE" no="24">
                    <text>This was caused by a complex mutation of the coupling site that can lead to an altered JNA, resulting in a premature arrest codon.</text>
                    <arg n="0">a complex mutation of the coupling site</arg>
                    <arg n="1">an altered JNA, resulting in a premature arrest codon</arg>
                </example>
                <example src="REPLACE" no="25">
                    <text>This was caused by inactivation of the MEF2C gene leads to morphogenetic cardiac defects, vascular abnormalities, and lethality per embryonic day 9.5.</text>
                    <arg n="0">inactivation of the MEF2C gene</arg>
                    <arg n="1">morphogenetic cardiac defects, vascular abnormalities, and lethality per embryonic day 9.5</arg>
                </example>
                <example src="REPLACE" no="26">
                    <text>This was caused by inactivation of the MEF2C gene which led to morphogenetic cardiac defects, vascular abnormalities and mortality at day 9.5 embryonic.</text>
                    <arg n="0">inactivation of the MEF2C gene</arg>
                    <arg n="1">morphogenetic cardiac defects, vascular abnormalities and mortality at day 9.5 embryonic</arg>
                </example>
                <example src="REPLACE" no="27">
                    <text>This was caused by the distinct termini amino acid that may lead to the direction of individual VDAC isoforms to different cellular compartments.</text>
                    <arg n="0">the distinct termini amino acid</arg>
                    <arg n="1">the direction of individual VDAC isoforms to different cellular compartments</arg>
                </example>
                <example src="REPLACE" no="28">
                    <text>Transduction of the MarA region from a sea strain, but not a wild-type strain, can lead to Display of the SNU246 gene in yeast.</text>
                    <arg n="0">Display of the SNU246 gene in yeast</arg>
                </example>
                <example src="REPLACE" no="29">
                    <text>Transduction of the mara region from a sea strain, but not a wild-type strain, leads to G979A affects a splice consensus site at the end of exon 8, and G1488T at exon 14.</text>
                    <arg n="0">G979A affects a splice consensus site at the end of exon 8, and G1488T at exon 14</arg>
                </example>
                <example src="REPLACE" no="30">
                    <text>a complex coupling site mutation DNA of patients contains This that led to an altered ARNJ1 resulting in a premature stop codon.</text>
                    <arg n="0">a complex coupling site mutation</arg>
                    <arg n="1">an altered ARNJ1 resulting in a premature stop codon</arg>
                </example>
                <example src="REPLACE" no="31">
                    <text>a complex mutation of the coupling site base pair G:C is also the strongest determinant in This that has led to an abnormal JAG1 mRNA, resulting in a premature halting codon (Lagrange et al., 1998).</text>
                    <arg n="0">a complex mutation of the coupling site</arg>
                    <arg n="1">an abnormal JAG1 mRNA, resulting in a premature halting codon</arg>
                </example>
                <example src="REPLACE" no="32">
                    <text>a complex mutation of the coupling site, in turn, is leading to an abnormal JAG1 mRNA, resulting in a premature halting codon regardless of the DNA binding activity of MEF2.</text>
                    <arg n="0">a complex mutation of the coupling site</arg>
                    <arg n="1">an abnormal JAG1 mRNA, resulting in a premature halting codon</arg>
                </example>
                <example src="REPLACE" no="33">
                    <text>a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S) was led to G979A affects a consensual site of the splice at the end of exon 8, and G1488T at exon 14.</text>
                    <arg n="0">G979A affects a consensual site of the splice at the end of exon 8, and G1488T at exon 14</arg>
                    <arg n="1">a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S)</arg>
                </example>
                <example src="REPLACE" no="34">
                    <text>a substitution of a positive charge in a highly conserved transmembrane domain (R496S) is led by G979A affects a consensus site of the splice at the end of exon 8, and G1488T at exon 14.</text>
                    <arg n="0">G979A affects a consensus site of the splice at the end of exon 8, and G1488T at exon 14</arg>
                    <arg n="1">a substitution of a positive charge in a highly conserved transmembrane domain (R496S)</arg>
                </example>
                <example src="REPLACE" no="35">
                    <text>disorganization of the SNU246 gene in the yeast basic pair G:C is also the strongest determinant in This leading to in vivo splicing defect, indicating that the protein is essential for splicing (Lagrange et al., 1998).</text>
                    <arg n="0">disorganization of the SNU246 gene in the yeast</arg>
                    <arg n="1">in vivo splicing defect, indicating that the protein is essential for splicing</arg>
                </example>
                <example src="REPLACE" no="36">
                    <text>disorganization of the SNU246 gene in the yeast can lead to in vivo splicing defect, indicating that the protein is essential for splicing.</text>
                    <arg n="0">disorganization of the SNU246 gene in the yeast</arg>
                    <arg n="1">in vivo splicing defect, indicating that the protein is essential for splicing</arg>
                </example>
                <example src="REPLACE" no="37">
                    <text>disorganization of the SNU246 gene in the yeast leads to in vivo splicing defect, indicating that the protein is essential for splicing.</text>
                    <arg n="0">disorganization of the SNU246 gene in the yeast</arg>
                    <arg n="1">in vivo splicing defect, indicating that the protein is essential for splicing</arg>
                </example>
                <example src="REPLACE" no="38">
                    <text>growth of Escherichia coli in the presence of nitrate or nitrite data suggests that This was able to lead to a 45% decrease in expression that works to stimulate phosphorylation and clustering of AchRs.</text>
                    <arg n="0">growth of Escherichia coli in the presence of nitrate or nitrite</arg>
                    <arg n="1">a 45% decrease in expression</arg>
                </example>
                <example src="REPLACE" no="39">
                    <text>inactivation of the MEF2C gene may lead to morphogenetic cardiac defects, vascular abnormalities and mortality at day 9.5 embryo coding an enzyme IITre of PTS for trealose and the TreC coding enzyme TreC, cytoplasmic trealose-6-phosphate-hydroxylase.</text>
                    <arg n="0">inactivation of the MEF2C gene</arg>
                    <arg n="1">morphogenetic cardiac defects, vascular abnormalities and mortality at day 9.5 embryo</arg>
                </example>
                <example src="REPLACE" no="40">
                    <text>inactivation of the MEF2C gene, in turn, is leading to morphogenetic cardiac defects, vascular abnormalities and mortality on the 9.5 embryonic day regardless of the DNA binding activity of MEF2.</text>
                    <arg n="0">inactivation of the MEF2C gene</arg>
                    <arg n="1">morphogenetic cardiac defects, vascular abnormalities and mortality on the 9.5 embryonic day</arg>
                </example>
                <example src="REPLACE" no="41">
                    <text>loss of the TreR function led to derepression of treB (figuration 3A).</text>
                    <arg n="0">loss of the TreR function</arg>
                    <arg n="1">derepression of treB</arg>
                </example>
                <example src="REPLACE" no="42">
                    <text>the distinct termini amino acid may lead to the direction of individual VDAC isoforms to different cellular compartments (figure 3A).</text>
                    <arg n="0">the distinct termini amino acid</arg>
                    <arg n="1">the direction of individual VDAC isoforms to different cellular compartments</arg>
                </example>
                <example src="REPLACE" no="43">
                    <text>two frame shifts and a mutation of the splice site data suggests that This has led to shortened OA1 proteins; removal of a threonine codon at position 290; and four opposite-sense mutations that works to stimulate phosphorylation and AchRs grouping.</text>
                    <arg n="0">two frame shifts and a mutation of the splice site</arg>
                    <arg n="1">shortened OA1 proteins; removal of a threonine codon at position 290; and four opposite-sense mutations</arg>
                </example>
                <example src="REPLACE" no="44">
                    <text>two frameshifts and a splice site mutation data suggests that This led to truncated proteins of OA1; a deletion of a threonine codon at position 290; and four absent mutations working to stimulate phosphorylation and clustering of AchRs.</text>
                    <arg n="0">two frameshifts and a splice site mutation</arg>
                    <arg n="1">truncated proteins of OA1; a deletion of a threonine codon at position 290; and four absent mutations</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
